â– LECTURE OVERVIEW: Tay-Sachs Disease is a fatal, progressive neurodegenerative lysosomal storage disease categorized as a GM2 gangliosidosis.
â– MOLECULAR GENETICS & HISTOLOGY:
1. Subunit Deletion: Caused by autosomal recessive mutations in the HEXA gene on chromosome 15, which encodes the alpha-subunit of the beta-Hexosaminidase A enzyme.
2. Ganglioside Saturation: Hexosaminidase A is responsible for degrading GM2 gangliosides in lysosomes. When deficient, GM2 ganglioside accumulates progressively to toxic levels in the central and autonomic nervous systems.
3. Neural Cytolysis: Axon tracts and neuronal cell bodies hypertrophy, undergo membrane disruption, and ultimately degenerate.
4. Onion Skin Lysosomes: Electron microscopy reveals classic 'onion skin' or whorled lysosomal configurations containing lipid-rich membrane fragments.
â– SURGICAL LANDMARKS & ANATOMICAL BOUNDARIES:
Intraoperative access requires meticulous dissection along defined tissue planes. Avoid excessive traction near neurovascular bundles and look for key bony landmarks or fascial reflections to secure margins.
â– ACUTE TOXICOLOGICAL PROFILE:
High cumulative chemical exposure or accidental overdose triggers systemic receptor overload, cellular injury, and metabolic acidosis.
[HY-BOARD-1173]
🌟 Dynamic Clinical Key:
Tay-Sachs presents in early infancy with developmental regression, hyperacusis (startle response), axial hypotonia, and a hallmark 'cherry-red spot' on fundoscopy (the pale lipid-laden macula framing the normal vascular red fovea). Clinically, it is distinguished from Niemann-Pick by the absolute absence of hepatosplenomegaly. Never divide or ligate any vessel before clearly isolating and confirming its origin and termination. Immediate administration of physiological charcoal or specific receptor antagonists is lifesaving.